Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Price to Cash Earnings (PCE)

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   PCE(x) 6.537.707.08-6.31-

What is the latest Price to Cash Earnings (PCE) ratio of NATH BIOGENES (INDIA) ?

The latest Price to Cash Earnings (PCE) ratio of NATH BIOGENES (INDIA) is 6.53 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20256.53
Mar20247.70
Mar20237.08
Mar2022-6.31
Mar2013-

How is Price to Cash Earnings (PCE) of NATH BIOGENES (INDIA) Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 6.53
-15.19
Mar2024 7.7
8.76
Mar2023 7.08
Positive
Mar2022 -6.31
0
Mar2013 0 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Price to Cash Earnings (PCE) ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹268.9 Cr -10.4% -15.2% -26.4% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,651.0 Cr 0.6% -3% -23% Stock Analytics
KAVERI SEED COMPANY ₹4,880.8 Cr -1.7% -6.7% 5.9% Stock Analytics
VENKYS (INDIA) ₹1,874.2 Cr -2% -12.5% -23.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,029.8 Cr -2.4% -14.5% -35.7% Stock Analytics
INDO US BIOTECH ₹257.2 Cr 2.2% -1.8% -49.9% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-10.4%

-15.2%

-26.4%

SENSEX

0%

2.7%

6.8%


You may also like the below Video Courses